Breaking News
Sort by:
Top Post
CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute
Actinium Pharmaceuticals, a leader in the development of targeted radiotherapies, have announced that it has […]
STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML
STORM Therapeutics, the clinical-stage biotechnology company discovering and developing novel small molecule therapies targeting RNA […]
Priothera Announces First Patients Enrolled in Pivotal Global Study for Patients with Acute Myeloid Leukemia
Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound […]
- ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more
- Superior HealthPlan and eFamilyCare Expand Partnership to Support Medicaid Members and Caregivers in Texas Read more
- Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform Read more
- FSD Pharma Receives Regulatory Clearance for Its Proposed Phase-1 Clinical Trial of Lucid-21-302 (Lucid-MS), First-in-Class Multiple Sclerosis Drug Candidate Read more
- $25 Million Gift to Penn Medicine and Children’s Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders Read more